As a leading provider of nitinol components and services, Resonetics participated in the 2024 SMST conference. The program was heavily focused on the latest research and development in nitinol, with Resonetics among other industry leaders presenting their work. Kevin Kelly, CEO of Resonetics, emphasized that this scientific focus is crucial for continuing to push the boundaries of what’s possible with nitinol, particularly in the growing medical device market.
Video